Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Modification of globin gene expression by RNA targeting strategies.

Modification of globin gene expression by RNA targeting strategies. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Modification of globin gene expression by RNA targeting strategies. Abstract Text:

    tong-jian shenTong-Jian Shen,heather rogersHeather Rogers,xiaobing yuXiaobing Yu,felix linFelix Lin,constance t noguchiConstance T Noguchi,chien hoChien Ho,

    OBJECTIVE: Sickle cell anemia is a genetic blood disease resulting from production of mutant beta-globin (beta(S)) and has severe clinical consequences. It is known that a higher cellular gamma-globin level, e.g., higher ratio of cellular gamma-globin to beta(S)-globin (gamma/beta(S) ratio), inhibits sickle hemoglobin (HbS) polymerization tendency. Hence, therapeutic treatment of sickle cell anemia has been focused on introducing gamma-globin gene into red blood cells to increase the cellular gamma/beta(S) ratio. Here, we have introduced ribozymes and small interfering RNAs (siRNAs) against beta(S)-globin mRNA into blood cells as a means to increase the gamma/beta(S) ratio. MATERIALS AND METHODS: Single and multiribozymes against beta(S)-globin mRNA have been tested in vitro and in human erythroleukemia K562beta(S) cells that stably express exogenous beta(S)-globin gene. Primary human hematopoietic progenitor cells were also transfected with multiribozyme and the gamma/(gamma + beta) ratio determined and compared with cells transfected with long hairpin beta-globin cDNA and synthetic siRNA genes. RESULTS: We have found that the multiribozyme zb21A containing two ribozyme units effectively reduces beta(S)-globin mRNA both in vitro and in K562beta(S) cells. The gamma-globin mRNA to beta(S)-globin mRNA ratio in the multiribozyme transfected cells is about a factor of 2 more than that in the control cells. We have also found that the gamma/(gamma + beta) ratio in the transfected hematopoietic progenitor cells is increased by more than twofold in cells treated with multiribozyme zb21A or siRNA ib5. CONCLUSION: Our results suggest that introducing multiribozymes or siRNAs into red blood cells is comparable in their effectiveness to increase the ratio of cellular gamma-globin mRNA to beta- or beta(S)-globin mRNA, providing possible strategies to increase the effectiveness of gamma-globin gene transfer as gene therapy for treatment of patients with sickle cell anemia.

    Modification of globin gene expression by RNA targeting strategies. Publishing Authors By Initials

    tj shenTJ Shen,h rogersH Rogers,x yuX Yu,f linF Lin,ct noguchiCT Noguchi,c hoC Ho,

    For similar nucleic acids, nucleotides, and nucleosides: antisense elements (genetics): rna, antisense: rna, small interfering research abstracts see: nucleic acids, nucleotides, and nucleosides: antisense elements (genetics): rna, antisense: rna, small interfering research

    PUBMED ID PMID:

    MEDLINE DATE:

    Modification of globin gene expression by RNA targeting strategies. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Experimental hematology

    VOLUME: 35

    Page Numbers: 1209-18

    Journal Abbreviation: Exp. Hematol.

    ISSN: 0301-472X

    DAY: 3

    MONTH: Aug

    YEAR: 2007

    Modification of globin gene expression by RNA targeting strategies. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 402313

    Modification of globin gene expression by RNA targeting strategies. Keywords Mesh Terms:

    KEYWORDS: RNA, Small Interfering

    MESH TERMS: genetics

    Chemical & Substance for Abstract: Modification of globin gene expression by RNA targeting strategies. Information

    Substance Name: Globins

    Registry Number: 9004-22-2

    Grant and Affiliation Information for Modification of globin gene expression by RNA targeting strategies.

    AFFILIATION: Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA 15213, USA.

    Country: Netherlands

    Netherlands Research PublicationNetherlands Research Publication

    AGENCY: United States NHLBI

    GRANT: R01HL-024525

    ACRONYM: HL

    MEDLINETA: Exp Hematol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Modification of globin gene expression by RNA targeting strategies Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News